SCHEMBL3776737

SCHEMBL3776737

CC(C)(C)N(Cc1ccc(C(=O)Nc2cc(-c3ccccc3)ncc2[N+](=O)[O-])cc1)C(=O)O

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.44
NPC1 O15118 3/20 0.44
MAPK1 P28482 3/20 0.44
RAB9A P51151 3/20 0.44
GLA P06280 1/20 0.44
CASP3 P42574 1/20 0.44
HTT P42858 1/20 0.44
SENP8 Q96LD8 1/20 0.44
SENP7 Q9BQF6 1/20 0.44
SENP6 Q9GZR1 1/20 0.44
MAPT P10636 4/20 0.44
POLB P06746 2/20 0.44
HCAR3 P49019 1/20 0.42
HDAC1 Q13547 4/20 0.41
HDAC3 O15379 1/20 0.41
HDAC2 Q92769 1/20 0.41
KMT2A Q03164 1/20 0.41
ABCB1 P08183 3/20 0.40
LMNA P02545 1/20 0.40
ABCC1 P33527 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3776743 1.00 ALDH1A1 (0.44) ALDH1A1NPC1MAPK1RAB9AGLA
SCHEMBL3774831 0.85 HDAC1 (0.53) HDAC1HDAC3HDAC2
SCHEMBL3644798 0.82 HPGDS (0.48) ALDH1A1MAPTPOLBHCAR3HDAC1
SCHEMBL3644793 0.82 HPGDS (0.48) ALDH1A1MAPTPOLBHCAR3HDAC1
SCHEMBL3772409 0.81 POLB (0.41) ALDH1A1NPC1MAPK1RAB9AGLA
SCHEMBL3772412 0.81 POLB (0.41) ALDH1A1NPC1MAPK1RAB9AGLA
SCHEMBL3777895 0.76 HDAC1 (0.54) HDAC1HDAC3HDAC2
SCHEMBL3644493 0.73 HDAC1 (0.74) HDAC1HDAC2
SCHEMBL3053167 0.71 HDAC1 (0.68) MAPK1HDAC1HDAC3HDAC2
SCHEMBL3775153 0.71 HDAC2 (0.48) HDAC1HDAC3HDAC2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8461189-B2 Pyridyl derivatives as histone deacetylase inhibitors MERCK SHARP & DOHME CORP. (US) 2013-06-11 US disclosed
US-20100324092-A1 PYRIDYL AND PYRIMIDINYL DERIVATIVES AS HISTONE DEACETYLASE INHIBITORS MERCK SHARP & DOHME CORP. 2010-12-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100324092-A1 PYRIDYL AND PYRIMIDINYL DERIVATIVES AS HISTONE DEACETYLASE INHIBITORS BRDT, HDAC5, HDAC1 ALDH1A1 966/4885NPC1 4279/4885MAPK1 853/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.